Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Cipla
Healthtrust
Dow
Citi
Chinese Patent Office
McKinsey
Cerilliant

Generated: January 23, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Afuresertib

« Back to Dashboard

US Patents for Afuresertib

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Afuresertib ➤ Try a Free Trial Inhibitors of Akt activity GlaxoSmithKline LLC (Philadelphia, PA) ➤ Try a Free Trial
Afuresertib ➤ Try a Free Trial Inhibitors of Akt activity GlaxoSmithKline LLC (Philadelphia, PA) ➤ Try a Free Trial
Afuresertib ➤ Try a Free Trial Pharmaceutical composition GlaxoSmithKline LLC (Philadelphia, PA) ➤ Try a Free Trial
Afuresertib ➤ Try a Free Trial Chemical compounds GlaxoSmithKline LLC (Philadelphia, PA) ➤ Try a Free Trial
Afuresertib ➤ Try a Free Trial Crystalline N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-m- ethyl-1H-pyrazol-5-yl)-2-thiophenecarboxamic hydrochloride GlaxoSmithKline LLC (Philadelphia, PA) ➤ Try a Free Trial
Afuresertib ➤ Try a Free Trial Combination of a B-Raf inhibitor: N-{3-[5-(2-Amino-4-pyrimidinyl)-2-(1,1- dimethylethyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfo- namide and the Akt inhibitor: N-{ (1S)-2-amino-1-[(3- fluorophenyl)methyl]ethyl}-5-chIoro-4-(4-chIoro- 1 -methyl- 1 H-pyrazol-5-yl)-2-10 thiophenecarboxamide useful in the treatment of cancer GlaxoSmithKline LLC (Wilmington, DE) ➤ Try a Free Trial
Afuresertib ➤ Try a Free Trial Inhibitors of AkT activity GlaxoSmithKline LLC (Wilmington, DE) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Afuresertib

Drugname Country Document Number Estimated Expiration Related US Patent
Afuresertib Argentina 066184 2027-02-07 ➤ Try a Free Trial
Afuresertib Australia 2008213694 2027-02-07 ➤ Try a Free Trial
Afuresertib Brazil PI0807146 2027-02-07 ➤ Try a Free Trial
Afuresertib Canada 2678255 2027-02-07 ➤ Try a Free Trial
Afuresertib Chile 2008000348 2027-02-07 ➤ Try a Free Trial
Afuresertib China 101646427 2027-02-07 ➤ Try a Free Trial
Afuresertib Colombia 6220930 2027-02-07 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
UBS
Cerilliant
Chubb
Queensland Health
Healthtrust
McKinsey
Teva
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.